General Information |
| Clinical trials phase |
Phase 1 |
| Start date (estimated) |
2025-09-08 |
| End date (estimated) |
2026-12-31 |
| Clinical feature |
| Label |
diabetic neuropathy |
| Link |
http://purl.obolibrary.org/obo/MONDO_0006626 |
| Description |
A chronic, pathological complication associated with diabetes mellitus, where nerve damages are incurred due to diabetic microvascular injury involving small blood vessels that supply these nerves, resulting in peripheral and/or autonomic nerve dysfunction. |
|
Administrative Information |
| ICTRP weblink |
https://trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR2500108862 |
| Other study identifiers |
| Name |
ChiCTR2500108862 |
| Description |
Chinese Clinical Trial Registry |
|
| Source weblink |
https://www.chictr.org.cn/showproj.html?proj=285996 |
| Study sites |
|
| Sponsors |
Beijing Hospital, National Center of Gerontology
|
Cells |
| Which differentiated cell type is used |
| Label |
Exosome |
| Link |
http://purl.obolibrary.org/obo/NCIT_C104457 |
| Description |
A secretory vesicle between 30 and 90 nm in diameter that can play a role in receptor recycling, plasma membrane protein shedding, and the secretion of proteins and RNA. |
|
Recruitment |
| Recruitment Status |
Not yet recruiting |
| Comment recruitment status |
Intervention group:20;Control group:20 |
| Estimated number of participants |
40 |
